Health Affairs June 17, 2020
The Trump Administration has delivered significant policy advancements to lower the price of drugs and spur greater competition and innovation in the American health care system. As a result of actions by the Centers for Medicare and Medicaid Services (CMS), the average basic premium for Medicare Part D prescription drug plans was projected to decline 13.5 percent since 2017, to the lowest level in seven years, saving beneficiaries about $1.9 billion in premium costs over that time. Most recently, in March, CMS announced the Senior Savings Model, where participating enhanced Part D prescription drug plans across the country will provide Medicare beneficiaries access to a broad set of insulins at a maximum $35 copay for a month’s supply, saving beneficiaries...
Today's Sponsors
Today's Sponsor